RxDoctor Payments Data

Regina Click

Family · Albuquerque, NMNPI 1871879171

Payments from drug & device makers

$1,578in general payments, 2019–2025

Across 78 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$306
  • Boehringer Ingelheim$176
  • Novo Nordisk$166
  • Exact Sciences$141
  • Neurocrine Biosciences, Inc.$119
  • AbbVie$114
  • plus $556 from 12 others

What the payments were for

  • Food & beverage$1,578100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,578 in reported general payments places this provider in the 85th percentile of 1,080 family providers in New Mexico.

See all family providers in New Mexico

Medicare billing

Part B allowed, 2024
$32,202
Medicare patients
176
Services billed
399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin27$30,528
TrulicityDulaglutide13$18,244
EliquisApixaban22$17,278
OzempicSemaglutide15$15,637
MounjaroTirzepatide15$15,457
JanuviaSitagliptin Phosphate11$5,889
Atorvastatin Calcium121$1,453
Levothyroxine Sodium85$1,141
Lisinopril94$767
Duloxetine Hcl23$684
Albuterol Sulfate HfaAlbuterol Sulfate27$684
Baclofen13$680
Gabapentin56$666
Losartan Potassium68$642
Amlodipine Besylate67$631

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$306$33,70028 claims
Boehringer IngelheimJardiance$176$30,52827 claims
PfizerEliquis$72$17,27822 claims
Novo NordiskOzempic$166$15,63715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,080 family providers in New Mexico.

Other family in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →